Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

NEWARK, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the fourth quarter and full year of fiscal 2023 - the

Related Keywords

Barbara Ryan ,Day Three Labs Inc ,Rafael Medical Devices ,Lipomedix Pharmaceuticals Ltd ,Cornerstone Pharmaceuticals ,Rafael Pharmaceuticals Inc ,Cornerstone Pharmaceuticals Inc ,Nasdaq ,Cyclo Therapeutics Inc ,Barer Institute ,Barer Institute Inc ,Other Pharmaceuticals ,Rafael Holdings ,Rafael Holdings Inc ,Bill Conkling ,Cyclo Therapeutics ,Day Three Laboratories ,Fourth Quarter Fiscal Year ,Full Year Fiscal ,Day Three Labs ,Private Securities Litigation Reform Act ,Annual Report ,Region ,